Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
An announcement from IdaCorp ( (IDA) ) is now available.
On May 8, 2025, IDACORP, Inc. entered into forward sale agreements with Morgan Stanley, JPMorgan Chase, and Wells Fargo, involving over 5 million shares of its common stock. These agreements, part of an underwritten public offering, allow IDACORP to issue shares by November 2026 at an initial forward sale price of $107.67 per share, subject to adjustments. The transactions are expected to have implications for IDACORP’s earnings per share, depending on the settlement method chosen, with potential dilution if shares are physically or net share settled.
Spark’s Take on IDA Stock
According to Spark, TipRanks’ AI Analyst, IDA is a Neutral.
IdaCorp demonstrates robust financial performance with significant growth prospects, although increased leverage and regulatory concerns present risks. The stock’s technical indicators are positive but nearing overbought levels, while the valuation remains reasonable. Overall, IdaCorp maintains a strong position with some caution needed regarding cost pressures and regulatory dynamics.
To see Spark’s full report on IDA stock, click here.
More about IdaCorp
Average Trading Volume: 395,080
Technical Sentiment Signal: Buy
Current Market Cap: $6.21B
Find detailed analytics on IDA stock on TipRanks’ Stock Analysis page.